摘要
Seasonal influenza still greatly threatens public health worldwide, leading to significant morbidity and mortality. Antiviral medications for influenza treatment are limited and accompanied by increased drug resistance. In severe influenza virus infection, hyperinflammation and hypoxia may be the significant threats associated with mortality, so the development of effective therapeutic methods to alleviate excessive inflammation while reducing viral damage is highly pursued. Here, a multifunctional MOF-based nanohybrid of CuTCPP@Mn3O4 as a novel drug against influenza A virus infection (MOF = metal-organic framework; TCPP = tetrakis (4-carboxyphenyl) porphyrin) is designed. CuTCPP@Mn3O4 exhibits potent inhibitory capability against influenza A virus infection in vitro and in vivo. The mechanism study reveals that CuTCPP@Mn3O4 inhibits the virus entry by binding to the HA2 subunit of influenza A virus hemagglutinin. In addition, the nanoparticles of Mn3O4 in CuTCPP@Mn3O4 can scavenge intracellular ROS with O(2 )generation to downregulate inflammatory factors and effectively inhibit cytokines production. By reconstructing the antioxidant microenvironment, CuTCPP@Mn3O4 features as a promising nanomedicine with anti-inflammatory and anti-viral synergistic effects.
学科与关键词
- Anti-Influenza Virus Study of Composite Material with MIL-101(Fe)-Adsorbed FavipiravirXu, Mengyuan; Li, Xi; Zheng, Huiying; Chen, Jiehan; Ye, Xiaohua; Liu, Tiantian*MOLECULES, 2022, 27(7): 2288.被引 11
- Multiple modes of action of myricetin in influenza A virus infectionSang, Huiting; Huang, Yingna; Tian, Yuanxin; Liu, Miaomiao; Chen, Liurong; Li, Lin; Liu, Shuwen; Yang, Jie*Phytotherapy Research, 2021, 35(5): 2797-2806.被引 12
- A "building block" approach to the new influenza A virus entry inhibitors with reduced cellular toxicitiesLin Dongguo; Li Fangfang; Wu Qiuyi; Xie Xiangkun; Wu Wenjiao; Wu Jie; Chen Qing; Liu Shuwen; He Jian*Scientific Reports, 2016, 6: 22790.
